These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15840601)

  • 21. Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients.
    Vitali C; Palombi G; Baldini C; Benucci M; Bombardieri S; Covelli M; Del Papa N; De Vita S; Epis O; Franceschini F; Gerli R; Govoni M; Bongi SM; Maglione W; Migliaresi S; Montecucco C; Orefice M; Priori R; Tavoni A; Valesini G
    Arthritis Rheum; 2007 Jul; 56(7):2223-31. PubMed ID: 17599741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sjögren's syndrome, hypersensitivity and HLA alleles.
    Panchovska MS
    Minerva Med; 2002 Feb; 93(1):79. PubMed ID: 11850616
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytokine mRNA expression in labial salivary glands and cytokine secretion in parotid saliva in Sjögren's syndrome.
    Fox PC; Grisius MM; Bermudez DK; Sun D
    Adv Exp Med Biol; 1998; 438():909-15. PubMed ID: 9634987
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
    Fox PC
    Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenetic aspects of humoral autoimmunity in Sjögren's syndrome.
    Tatouli IP; Tzioufas AG
    Lupus; 2012 Oct; 21(11):1151-4. PubMed ID: 22898537
    [No Abstract]   [Full Text] [Related]  

  • 26. Endothelial specialization of salivary gland vessels for accelerated lymphocyte transfer in Sjögren's syndrome.
    Freemont AJ; Jones CJ
    J Rheumatol; 1983 Oct; 10(5):801-4. PubMed ID: 6644704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome.
    Tuisku IS; Konttinen YT; Konttinen LM; Tervo TM
    Exp Eye Res; 2008 Jun; 86(6):879-85. PubMed ID: 18436208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IDD3 and IDD5 alleles from nod mice mediate Sjögren's syndrome-like autoimmunity.
    Cha S; Nagashima H; Peck AB; Humphreys-Beher MG
    Adv Exp Med Biol; 2002; 506(Pt B):1035-9. PubMed ID: 12614028
    [No Abstract]   [Full Text] [Related]  

  • 29. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
    Hoffman RW
    Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
    [No Abstract]   [Full Text] [Related]  

  • 30. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
    Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
    J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polarization of B effector cells in Sjögren's syndrome.
    Daridon C; Guerrier T; Devauchelle V; Saraux A; Pers JO; Youinou P
    Autoimmun Rev; 2007 Aug; 6(7):427-31. PubMed ID: 17643928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome.
    Limaye V; Lester S; Downie-Doyle S; Pile K; Bardy P; Gordon TP; Rischmueller M
    J Rheumatol; 2000 Dec; 27(12):2945-6. PubMed ID: 11128696
    [No Abstract]   [Full Text] [Related]  

  • 33. Interview with Haralampos M. Moutsopoulos. What's going to happen as far as the natural history of Sjögren's syndrome is concerned?. Interview by Pierre Youinou.
    Moutsopoulos HM
    Ann Med Interne (Paris); 1994; 145(3):175-6. PubMed ID: 8092631
    [No Abstract]   [Full Text] [Related]  

  • 34. [Familial Sjögren's syndrome, pseudolymphoma and selective C4 deficiency associated with cryoglobulinemia].
    Batlle Fondrodona J; Cordero Sánchez M; Martínez López de Letona J; López Borrasca A
    Rev Clin Esp; 1980 Sep; 158(6):321-5. PubMed ID: 7209029
    [No Abstract]   [Full Text] [Related]  

  • 35. [New insight on the physiopathology of autoimmune diseases].
    Nau JY
    Rev Med Suisse; 2006 Mar; 2(56):687. PubMed ID: 16597060
    [No Abstract]   [Full Text] [Related]  

  • 36. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome.
    Mackay F; Groom JR; Tangye SG
    Curr Opin Rheumatol; 2007 Sep; 19(5):406-13. PubMed ID: 17762603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary Sjögren syndrome].
    Genth E
    Dtsch Med Wochenschr; 1986 Oct; 111(41):1578-9. PubMed ID: 3769797
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts.
    Ramos-Casals M; Font J
    Rheumatology (Oxford); 2005 Nov; 44(11):1354-67. PubMed ID: 15956090
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gougerot-Sjögren syndrome].
    Humbert P; Dupond JL; Renaud A
    Soins; 1987 Dec; (507):25-6. PubMed ID: 3438748
    [No Abstract]   [Full Text] [Related]  

  • 40. Locus DR in primary Sjögren's syndrome.
    Panchovska M; Sheitanov Y; Martinova F
    Bratisl Lek Listy; 2001; 102(8):382. PubMed ID: 11763672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.